Israeli Scientists Create New Breath Test To Detect Cancer
Scientists from the University of Latvia and the Israel Institute of Technology say that a new breath test can help to detect gastric and stomach cancer as well as precancerous lesions in high risk patients.
Called the “nanoarray”, the new breath test was developed by Professor Hossam Haick of the Department of Chemical Engineering and Russell Berrie of the Nanotechnology Institute in Israel. Haick and Berrie were hopeful for a test that would not only be particularly effective in determining whether or not a patient was at risk, but also a test that would be accessible to the largest number of people. The “nanoarray” is a very low cost option for patients with limited to no insurance coverage.
Initial trials of the breath test were conducted on over four-hundred patients, ninety-nine of whom had already been diagnosed with varying stages of stomach cancer. Thus far, the test has proven to be over ninety percent (90%) accurate.
